Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project
ConditionMucormycosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorM.D. Anderson Cancer Center
About this trial
To collect data and samples from participants with cancer who also have invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection.
Eligibility criteria
Qualifiers
Patients must be 18-100 years old and have cancer and invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection but no evidence of such infection.
Patients must be willing to undergo routine diagnostic procedures (e.g., phlebotomy, bronchoscopy, biopsy) as part of their regular care.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Mucormycosis
Treatment groups
300 Participants
are divided into 4 treatment groupsLocations
1MD Anderson Cancer Center77030, HoustonTexas, United States
Sponsors and collaborators
M.D. Anderson Cancer Center
Lead sponsor
Source ClinicalTrials.gov